Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents
Clinical trial NCT02928263 · WITHDRAWN
Trial details
- NCT number
- NCT02928263
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-28
- Primary completion
- 2017-05-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.